US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Creative Medical Technology Holdings Inc (CELZ)
Creative Medical Technology Holdings Inc (CELZ) ニュース

CELZ

Creative Medical Technol... (CELZ)

Creative Medical Technology Holdings Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CELZ

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/03/27	22 : 00	Business Wire	Creative Medical Technology Holdings Provides Corporate Update	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2024/03/07	23 : 15	Business Wire	Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2024/03/07	06 : 10	AllPennyStocks.com	Biotech Finds Mid-Week Success Following FDA Announcement	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2024/03/06	21 : 00	Business Wire	Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/12/21	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/11/15	22 : 00	PR Newswire (US)	Creative Medical Technology Holdings Provides Corporate Update	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/11/04	05 : 05	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/10/10	21 : 00	PR Newswire (US)	Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/09/19	21 : 00	PR Newswire (US)	Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/08/12	05 : 45	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/06/30	06 : 38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/06/30	06 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/06/28	22 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/06/28	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/06/28	21 : 00	PR Newswire (US)	Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/06/12	21 : 01	PR Newswire (US)	Creative Medical Technology Announces $2 Million Share Repurchase Program	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/06/12	21 : 00	PR Newswire (US)	Creative Medical Technology Holdings Provides Corporate Update	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/06/10	05 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/06/10	01 : 30	PR Newswire (US)	Creative Medical Technology Holdings Announces Reverse Stock Split	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/05/31	21 : 00	PR Newswire (US)	Creative Medical Technology Holdings Announces Successful Completion of the First Phase of its Program with Greenstone Biosciences, Inc. to Develop Next Generation iPSC Pipeline for ImmCelz® Immunotherapy Platform	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/05/22	21 : 30	PR Newswire (US)	Creative Medical Technology Holdings Announces Next Milestone Achievements in ImmCelz® Platform Development	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/05/18	21 : 00	PR Newswire (US)	Creative Medical Technology Holdings Announces Positive Top-Line Study Results for Chronic Lower Back Pain Utilizing its StemSpine® Procedure Using AlloStem™ Allogenic Cell Line	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/05/13	05 : 32	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/05/02	05 : 47	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/04/13	04 : 30	AllPennyStocks.com	Biotech Up Massively On Follow-Up Data	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/04/12	21 : 00	PR Newswire (US)	Creative Medical Technology Announces Positive Top-Line Results for Type 2 Diabetes Study	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/04/04	21 : 00	PR Newswire (US)	Creative Medical Technology Holdings Announces Filing of 2022 Form 10-K and Provides Business Update	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/04/01	05 : 47	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/03/23	21 : 00	PR Newswire (US)	Creative Medical Technology Files Orphan Drug Designation Application with the U.S. FDA Using the ImmCelz® Platform for the Treatment of Brittle Type 1 Diabetes	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/03/21	21 : 00	PR Newswire (US)	Creative Medical Technology Holdings Announces Key Milestones Regarding ImmCelz® Platform Development	NASDAQ:CELZ	Creative Medical Technology Holdings Inc

Showing the most relevant articles for your search:NASDAQ:CELZ

1 2 3 次へ >>

Verizon Communications

US Dollar vs Euro

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約